Review




Structured Review

Vigene Biosciences plasmid constructs encoding usp7
KIF23 and myosin heavy chain 9 (MYH9) interact with ubiquitin‐specific protease 7 <t>(USP7).</t> (A) Molecular docking results for KIF23 and MYH9. (B) Co‐immunoprecipitation (Co‐IP) analysis to detect the interaction between KIF23 and MYH9 in CC cells. (C) Immunofluorescence (IF) analysis showing the co‐localisation of KIF23 and MYH9 in CC cells (scale bar: 10 µm). (D) Reverse transcription‐quantitative polymerase chain reaction (RT‐qPCR) analysis of MYH9 mRNA levels in CC cells with or without KIF23 KO. (E) Western blotting (WB) analysis of MYH9 protein levels in CC cells with or without KIF23 KO. (F) Nuclear and cytoplasmic fractionation assay to detect MYH9 protein levels in overexpression KIF23 (oe‐ KIF23 ) CC cells. (G) Schematic diagram of the functional domains of KIF23. (H) Co‐IP assay demonstrating the interaction between different KIF23 domains and MYH9 in HEK‐293T cells transfected with the corresponding constructs. (I) Schematic diagram of the functional domains of MYH9. (J) Co‐IP assay demonstrating the interaction between different MYH9 domains and KIF23 in HEK‐293T cells. (K and L) Molecular docking diagrams of MYH9 with USP7 and KIF23 with USP7. (M) Co‐IP analysis in CC cells demonstrating the interactions of MYH9 and KIF23 with USP7. (N and O) Representative confocal images showing the co‐localisation of MYH9 with USP7 and KIF23 with USP7 (scale bar: 10 µm).
Plasmid Constructs Encoding Usp7, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+constructs/flag+tagged+usp7/pmc13052040-64-5-12
Average 86 stars, based on 1 article reviews
plasmid constructs encoding usp7 - by Bioz Stars, 2026-10
86/100 stars

Images

1) Product Images from "Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway"

Article Title: Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway

Journal: Clinical and Translational Medicine

doi: 10.1002/ctm2.70652

KIF23 and myosin heavy chain 9 (MYH9) interact with ubiquitin‐specific protease 7 (USP7). (A) Molecular docking results for KIF23 and MYH9. (B) Co‐immunoprecipitation (Co‐IP) analysis to detect the interaction between KIF23 and MYH9 in CC cells. (C) Immunofluorescence (IF) analysis showing the co‐localisation of KIF23 and MYH9 in CC cells (scale bar: 10 µm). (D) Reverse transcription‐quantitative polymerase chain reaction (RT‐qPCR) analysis of MYH9 mRNA levels in CC cells with or without KIF23 KO. (E) Western blotting (WB) analysis of MYH9 protein levels in CC cells with or without KIF23 KO. (F) Nuclear and cytoplasmic fractionation assay to detect MYH9 protein levels in overexpression KIF23 (oe‐ KIF23 ) CC cells. (G) Schematic diagram of the functional domains of KIF23. (H) Co‐IP assay demonstrating the interaction between different KIF23 domains and MYH9 in HEK‐293T cells transfected with the corresponding constructs. (I) Schematic diagram of the functional domains of MYH9. (J) Co‐IP assay demonstrating the interaction between different MYH9 domains and KIF23 in HEK‐293T cells. (K and L) Molecular docking diagrams of MYH9 with USP7 and KIF23 with USP7. (M) Co‐IP analysis in CC cells demonstrating the interactions of MYH9 and KIF23 with USP7. (N and O) Representative confocal images showing the co‐localisation of MYH9 with USP7 and KIF23 with USP7 (scale bar: 10 µm).
Figure Legend Snippet: KIF23 and myosin heavy chain 9 (MYH9) interact with ubiquitin‐specific protease 7 (USP7). (A) Molecular docking results for KIF23 and MYH9. (B) Co‐immunoprecipitation (Co‐IP) analysis to detect the interaction between KIF23 and MYH9 in CC cells. (C) Immunofluorescence (IF) analysis showing the co‐localisation of KIF23 and MYH9 in CC cells (scale bar: 10 µm). (D) Reverse transcription‐quantitative polymerase chain reaction (RT‐qPCR) analysis of MYH9 mRNA levels in CC cells with or without KIF23 KO. (E) Western blotting (WB) analysis of MYH9 protein levels in CC cells with or without KIF23 KO. (F) Nuclear and cytoplasmic fractionation assay to detect MYH9 protein levels in overexpression KIF23 (oe‐ KIF23 ) CC cells. (G) Schematic diagram of the functional domains of KIF23. (H) Co‐IP assay demonstrating the interaction between different KIF23 domains and MYH9 in HEK‐293T cells transfected with the corresponding constructs. (I) Schematic diagram of the functional domains of MYH9. (J) Co‐IP assay demonstrating the interaction between different MYH9 domains and KIF23 in HEK‐293T cells. (K and L) Molecular docking diagrams of MYH9 with USP7 and KIF23 with USP7. (M) Co‐IP analysis in CC cells demonstrating the interactions of MYH9 and KIF23 with USP7. (N and O) Representative confocal images showing the co‐localisation of MYH9 with USP7 and KIF23 with USP7 (scale bar: 10 µm).

Techniques Used: Ubiquitin Proteomics, Immunoprecipitation, Co-Immunoprecipitation Assay, Immunofluorescence, Reverse Transcription, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Western Blot, Fractionation, Over Expression, Functional Assay, Transfection, Construct

KIF23 induces K48‐linked deubiquitination of MYH9 through recruitment of USP7. (A) Western blotting (WB) analysis of MYH9 protein stability at different time points following cycloheximide (CHX) treatment in control and KIF23 KO groups. (B) CHX chase assay examining the regulation of MYH9 protein stability by USP7 overexpression (oe‐ USP7 ). (C) Effect of MG132 treatment (12 h) on MYH9 protein stability in KIF23 KO CC cells and their controls. (D) Co‐IP and WB analyses of the effect of KIF23 KO on MYH9 ubiquitination levels after 12 h of MG132 treatment. (E) Co‐IP and WB assays assessing the effects of control, KIF23 KO and KIF23 KO combined with USP7 overexpression (KO‐ KIF23 + oe‐ USP7 ) on MYH9 ubiquitination after 12 h of MG132 treatment in SIHA (left) and C33A (right) cells.
Figure Legend Snippet: KIF23 induces K48‐linked deubiquitination of MYH9 through recruitment of USP7. (A) Western blotting (WB) analysis of MYH9 protein stability at different time points following cycloheximide (CHX) treatment in control and KIF23 KO groups. (B) CHX chase assay examining the regulation of MYH9 protein stability by USP7 overexpression (oe‐ USP7 ). (C) Effect of MG132 treatment (12 h) on MYH9 protein stability in KIF23 KO CC cells and their controls. (D) Co‐IP and WB analyses of the effect of KIF23 KO on MYH9 ubiquitination levels after 12 h of MG132 treatment. (E) Co‐IP and WB assays assessing the effects of control, KIF23 KO and KIF23 KO combined with USP7 overexpression (KO‐ KIF23 + oe‐ USP7 ) on MYH9 ubiquitination after 12 h of MG132 treatment in SIHA (left) and C33A (right) cells.

Techniques Used: Western Blot, Control, Over Expression, Co-Immunoprecipitation Assay, Ubiquitin Proteomics

Related Articles

Transfection:

Article Title: Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway
Article Snippet: .. CC cells were transfected with plasmid constructs encoding USP7 (Miaoling Biology), MYH9 (Vigene Biosciences), MCM2 (Miaoling Biology) and USP15 (Miaoling Biology) using Lipofectamine 3000 (model L2000‐015; Invitrogen) as per the manufacturer's protocols. ..

Plasmid Preparation:

Article Title: Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway
Article Snippet: .. CC cells were transfected with plasmid constructs encoding USP7 (Miaoling Biology), MYH9 (Vigene Biosciences), MCM2 (Miaoling Biology) and USP15 (Miaoling Biology) using Lipofectamine 3000 (model L2000‐015; Invitrogen) as per the manufacturer's protocols. ..

Construct:

Article Title: Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway
Article Snippet: .. CC cells were transfected with plasmid constructs encoding USP7 (Miaoling Biology), MYH9 (Vigene Biosciences), MCM2 (Miaoling Biology) and USP15 (Miaoling Biology) using Lipofectamine 3000 (model L2000‐015; Invitrogen) as per the manufacturer's protocols. ..



Similar Products

91
Addgene inc slug promoter reporter construct
Slug Promoter Reporter Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+constructs/Slug_pGL2+(Plasmid+%2331695)/pm42894010-562-5-16
Average 91 stars, based on 1 article reviews
slug promoter reporter construct - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

94
Addgene inc ha mrin2 dra constructs
Ha Mrin2 Dra Constructs, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+constructs/HA-mRIN2+dRA+(Plasmid+%23108941)/pm42891565-190-57-60
Average 94 stars, based on 1 article reviews
ha mrin2 dra constructs - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
Addgene inc doxycycline inducible teto rfxcas13d blast construct
Doxycycline Inducible Teto Rfxcas13d Blast Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+constructs/pLentiRNACRISPR_007+-+TetO-NLS-RfxCas13d-NLS-WPRE-EFS-rtTA3-2A-Blast+(Plasmid+%23138149)/pmc13674509-279-7-10
Average 94 stars, based on 1 article reviews
doxycycline inducible teto rfxcas13d blast construct - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
Addgene inc gas5 overexpression construct
Gas5 Overexpression Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+constructs/LeGO-lnc-MONC+(Plasmid+%2386966)/pm42875649-281-1-12
Average 94 stars, based on 1 article reviews
gas5 overexpression construct - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
Addgene inc crispr guide constructs targeting tet1
Crispr Guide Constructs Targeting Tet1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+constructs/lentiCRISPR+v2-Blast+(Plasmid+%2383480)/pm42869907-371-0-18
Average 96 stars, based on 1 article reviews
crispr guide constructs targeting tet1 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

96
Addgene inc lentiviral dcas9 krab expression construct
Lentiviral Dcas9 Krab Expression Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+constructs/pLV+hU6-sgRNA+hUbC-dCas9-KRAB-T2a-Puro+(Plasmid+%2371236)/pm42868712-126-1-5
Average 96 stars, based on 1 article reviews
lentiviral dcas9 krab expression construct - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

94
Addgene inc construct encoding nanoluc luciferase nluc
Construct Encoding Nanoluc Luciferase Nluc, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+constructs/pET20b-NLuc-MBP-6xHis+(Plasmid+%23135931)/pm42869022-943-1-9
Average 94 stars, based on 1 article reviews
construct encoding nanoluc luciferase nluc - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
Addgene inc w attb construct
W Attb Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+constructs/w%2BattB+(Plasmid+%2330326)/pm42859193-271-12-14
Average 94 stars, based on 1 article reviews
w attb construct - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
Addgene inc mouse zdhhc16 expression construct
Mouse Zdhhc16 Expression Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+constructs/pcDNA3%2E1(%2B)+eGFP+(Plasmid+%23129020)/10__1016_slash_j__identj__2026__111204-64-4-16
Average 93 stars, based on 1 article reviews
mouse zdhhc16 expression construct - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

91
Addgene inc yfp tagged dbn drebrin yfp construct
(A) HEp-2 cells were “mock” infected (NI) or infected with RSV for 24 h, at MOI 1 and processed for IP using M antibodies. Input (1 %), unbound (1 %) and bound (30 %) fractions were loaded on SDS-PAGE and a Western blot was performed using antibodies indicated on the left. Representative of three independent experiments. (B) <t>HEp-2-Drebrin-YFP</t> and HEp-2-YFP cells were infected with RSV for 24 h, at MOI 1 and processed for IP using anti-GFP nanobodies. Input (0,5 %), unbound (0,5 %) and bound (30 %) fractions were loaded on SDS-PAGE and a Western blot was performed using antibodies indicated on the left. Drebrin-YFP and YFP corresponding bands were indicated by an arrow on the left. Representative of three independent experiments.
Yfp Tagged Dbn Drebrin Yfp Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+constructs/drebrin-YFP+(Plasmid+%2340359)/bio_rxiv__64898__2026__10__05__756730-223-0-8
Average 91 stars, based on 1 article reviews
yfp tagged dbn drebrin yfp construct - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

Image Search Results


(A) HEp-2 cells were “mock” infected (NI) or infected with RSV for 24 h, at MOI 1 and processed for IP using M antibodies. Input (1 %), unbound (1 %) and bound (30 %) fractions were loaded on SDS-PAGE and a Western blot was performed using antibodies indicated on the left. Representative of three independent experiments. (B) HEp-2-Drebrin-YFP and HEp-2-YFP cells were infected with RSV for 24 h, at MOI 1 and processed for IP using anti-GFP nanobodies. Input (0,5 %), unbound (0,5 %) and bound (30 %) fractions were loaded on SDS-PAGE and a Western blot was performed using antibodies indicated on the left. Drebrin-YFP and YFP corresponding bands were indicated by an arrow on the left. Representative of three independent experiments.

Journal: bioRxiv

Article Title: The actin-binding protein drebrin interacts with the respiratory syncytial virus matrix protein and promotes virus particle release

doi: 10.64898/2026.10.05.756730

Figure Lengend Snippet: (A) HEp-2 cells were “mock” infected (NI) or infected with RSV for 24 h, at MOI 1 and processed for IP using M antibodies. Input (1 %), unbound (1 %) and bound (30 %) fractions were loaded on SDS-PAGE and a Western blot was performed using antibodies indicated on the left. Representative of three independent experiments. (B) HEp-2-Drebrin-YFP and HEp-2-YFP cells were infected with RSV for 24 h, at MOI 1 and processed for IP using anti-GFP nanobodies. Input (0,5 %), unbound (0,5 %) and bound (30 %) fractions were loaded on SDS-PAGE and a Western blot was performed using antibodies indicated on the left. Drebrin-YFP and YFP corresponding bands were indicated by an arrow on the left. Representative of three independent experiments.

Article Snippet: YFP-tagged DBN (drebrin-YFP) construct has been provided from addgene (#40359).

Techniques: Infection, SDS Page, Western Blot

Drebrin promotes viral particle release . (A) Schematic representation of the release assay. HEp-2 cells were transfected with control or specific siRNAs and seeded onto Transwell inserts for 48h (step 1). Cells were then infected with RSV-mCherry at an MOI of 1 (step 2). After washes to remove non-internalized virus, the infected “donor” cells were then placed in contact with target cells (step 3). The number of infected “donor” and “target” cells were quantified based on mCherry fluorescence using the Incucyte S3 system at 20h (step4) and 38h (step 5) post-infection respectively. RSV release efficiency was calculated as the ratio of infected target cells to infected donor cells and normalized to the control siRNA condition. (B) HEp-2 cells were transfected with si NT or drebrin-specific siRNAs (si drebrin) and release assay was performed as described in A. Date are mean ± SD of 6 independent experiments, each point represents mean of triplicates. Y axis represents viral release efficiency (ratio of infected target cells to infected donor cells) normalized to the control siRNA condition. (C) release assay was performed with HEp-2-YFP and HEp-2-Drebrin-YFP cells. Data are mean ± SD of 4 independent experiments done in triplicates. Y axis represents viral release efficiency (ratio of infected target cells to infected donor cells) normalized to the control siRNA condition. (B-C) A one-sample t-test was performed. * : P < 0.05; ** : P < 0.001.

Journal: bioRxiv

Article Title: The actin-binding protein drebrin interacts with the respiratory syncytial virus matrix protein and promotes virus particle release

doi: 10.64898/2026.10.05.756730

Figure Lengend Snippet: Drebrin promotes viral particle release . (A) Schematic representation of the release assay. HEp-2 cells were transfected with control or specific siRNAs and seeded onto Transwell inserts for 48h (step 1). Cells were then infected with RSV-mCherry at an MOI of 1 (step 2). After washes to remove non-internalized virus, the infected “donor” cells were then placed in contact with target cells (step 3). The number of infected “donor” and “target” cells were quantified based on mCherry fluorescence using the Incucyte S3 system at 20h (step4) and 38h (step 5) post-infection respectively. RSV release efficiency was calculated as the ratio of infected target cells to infected donor cells and normalized to the control siRNA condition. (B) HEp-2 cells were transfected with si NT or drebrin-specific siRNAs (si drebrin) and release assay was performed as described in A. Date are mean ± SD of 6 independent experiments, each point represents mean of triplicates. Y axis represents viral release efficiency (ratio of infected target cells to infected donor cells) normalized to the control siRNA condition. (C) release assay was performed with HEp-2-YFP and HEp-2-Drebrin-YFP cells. Data are mean ± SD of 4 independent experiments done in triplicates. Y axis represents viral release efficiency (ratio of infected target cells to infected donor cells) normalized to the control siRNA condition. (B-C) A one-sample t-test was performed. * : P < 0.05; ** : P < 0.001.

Article Snippet: YFP-tagged DBN (drebrin-YFP) construct has been provided from addgene (#40359).

Techniques: Release Assay, Transfection, Control, Infection, Virus, Fluorescence

(A) diagrams of drebrin mutants are shown. ADFH, actin-depolymerizing factor homology domain. ABD1, actin binding domain 1. ABD2, actin binding domain 2. IDD intrinsically disordered domain. Constructs are YFP-tagged at the C-terminus. Numbering is for human drebrin E. (B) HEp-2 cells lines were established with the indicated plasmids and cells were infected with RSV for 24h at MOI 1 and processed for IP using anti-GFP nanobodies. Input (0,5 %), unbound (0,5 %) and bound (30 %) fractions were loaded on SDS-PAGE and Western blotting using antibodies indicated on the left. Representative of three independent experiments. (C) release assay was performed as in with cells expressing indicated plasmids. Data are mean ± SD of 6 independent experiments done in triplicates. Y axis represents viral release efficiency (ratio of infected target cells to infected donor cells) normalized to the control siRNA condition. One-Way ANOVA with Dunnett’s multiple comparisons test and Geisser-Greenhouse correction was performed, ns : P > 0.05, ** : P < 0.01, **** : P < 0.0001.

Journal: bioRxiv

Article Title: The actin-binding protein drebrin interacts with the respiratory syncytial virus matrix protein and promotes virus particle release

doi: 10.64898/2026.10.05.756730

Figure Lengend Snippet: (A) diagrams of drebrin mutants are shown. ADFH, actin-depolymerizing factor homology domain. ABD1, actin binding domain 1. ABD2, actin binding domain 2. IDD intrinsically disordered domain. Constructs are YFP-tagged at the C-terminus. Numbering is for human drebrin E. (B) HEp-2 cells lines were established with the indicated plasmids and cells were infected with RSV for 24h at MOI 1 and processed for IP using anti-GFP nanobodies. Input (0,5 %), unbound (0,5 %) and bound (30 %) fractions were loaded on SDS-PAGE and Western blotting using antibodies indicated on the left. Representative of three independent experiments. (C) release assay was performed as in with cells expressing indicated plasmids. Data are mean ± SD of 6 independent experiments done in triplicates. Y axis represents viral release efficiency (ratio of infected target cells to infected donor cells) normalized to the control siRNA condition. One-Way ANOVA with Dunnett’s multiple comparisons test and Geisser-Greenhouse correction was performed, ns : P > 0.05, ** : P < 0.01, **** : P < 0.0001.

Article Snippet: YFP-tagged DBN (drebrin-YFP) construct has been provided from addgene (#40359).

Techniques: Binding Assay, Construct, Infection, SDS Page, Western Blot, Release Assay, Expressing, Control

(A) Drebrin-YFP HEp-2 cells were uninfected or infected with RSV at MOI 1 for 24 h. Proteins associated with drebrin-YFP were affinity-purified using GFP nanobody-coupled agarose beads, identified by mass spectrometry, and quantified based on spectral counts obtained for each sample. A log2 fold change was calculated by comparing RSV-infected and uninfected conditions. Only proteins with at least two spectral counts in at least two biological replicates in either condition were included in the analysis. Statistical significance was assessed using a beta-binomial test adapted for spectral count data. Results are presented as a volcano plot. The horizontal dashed gray line indicates the statistical significance threshold ( P < 0.05), whereas the vertical dashed gray lines indicate a twofold difference between infected and uninfected samples. Cellular proteins used in C are indicated in blue. Viral RSV proteins are indicated in black. Results from three independent biological replicates (B) Left: Heat map of RT-qPCR analysis comparing mRNA levels of 17 candidate proteins in RSV-infected and uninfected cells. Blue indicates > 3-fold upregulation and yellow < 3-fold. Right: Heat map of viral replication analysis comparing RSV-mCherry signal in RSV-infected cells treated with interactors-specific siRNA and si NT. Blue indicates replication >140%, brown replication < 60% and yellow 60% < replication >140%. Complete data are shown in Fig S8. (C) HEp-2 cells were depleted with the indicated siRNAs and viral release assay was performed and compared with control conditions. One-Way ANOVA with Dunnett’s multiple comparisons test and Geisser-Greenhouse correction was performed relative to si NT. *** : P <0.001, ns : P >0,05.

Journal: bioRxiv

Article Title: The actin-binding protein drebrin interacts with the respiratory syncytial virus matrix protein and promotes virus particle release

doi: 10.64898/2026.10.05.756730

Figure Lengend Snippet: (A) Drebrin-YFP HEp-2 cells were uninfected or infected with RSV at MOI 1 for 24 h. Proteins associated with drebrin-YFP were affinity-purified using GFP nanobody-coupled agarose beads, identified by mass spectrometry, and quantified based on spectral counts obtained for each sample. A log2 fold change was calculated by comparing RSV-infected and uninfected conditions. Only proteins with at least two spectral counts in at least two biological replicates in either condition were included in the analysis. Statistical significance was assessed using a beta-binomial test adapted for spectral count data. Results are presented as a volcano plot. The horizontal dashed gray line indicates the statistical significance threshold ( P < 0.05), whereas the vertical dashed gray lines indicate a twofold difference between infected and uninfected samples. Cellular proteins used in C are indicated in blue. Viral RSV proteins are indicated in black. Results from three independent biological replicates (B) Left: Heat map of RT-qPCR analysis comparing mRNA levels of 17 candidate proteins in RSV-infected and uninfected cells. Blue indicates > 3-fold upregulation and yellow < 3-fold. Right: Heat map of viral replication analysis comparing RSV-mCherry signal in RSV-infected cells treated with interactors-specific siRNA and si NT. Blue indicates replication >140%, brown replication < 60% and yellow 60% < replication >140%. Complete data are shown in Fig S8. (C) HEp-2 cells were depleted with the indicated siRNAs and viral release assay was performed and compared with control conditions. One-Way ANOVA with Dunnett’s multiple comparisons test and Geisser-Greenhouse correction was performed relative to si NT. *** : P <0.001, ns : P >0,05.

Article Snippet: YFP-tagged DBN (drebrin-YFP) construct has been provided from addgene (#40359).

Techniques: Infection, Affinity Purification, Mass Spectrometry, Analysis, Quantitative RT-PCR, Release Assay, Control, Significance Assay